The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the Global “Immunodiagnostics” Market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.
Highlights of the Immunodiagnostics Market Report Include:
Key Players Operating in The Immunodiagnostics Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444
The report focuses on global major leading industry players of market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. This report focuses on Immunodiagnostics Market Trend, volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immunodiagnostics Market Size by analysing historical data and future prospect.
With tables and figures helping analyse worldwide Immunodiagnostics Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Abbott, DiaSorin, and Roche Diagnostics are Likely to Hold Significant Share in the Market
Prominent organizations such as Abbott, DiaSorin, and Roche Diagnostics are projected to lead the global immunodiagnostics market during the forecast period. Development strategies, rise in the investments in research and development, cost management, and strong supply chain network are predicted to give impetus to these companies and enable them gain a competitive edge.
Oncology and Endocrinology Segment Will Witness Increasing Demand
The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.
Objective of Studies:
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunodiagnostics-market-100444
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Technological Advancements
4.2 Key Industry Developments -Mergers, Acquisitions and Partnerships
4.3 Reimbursement Scenario
4.4 Key Performance Indicators for Global Immunodiagnostics Market
5. Global Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Product
5.2.1 Instruments
5.2.2 Reagents and Consumables
5.3. Market Analysis, Insights and Forecast By Application
5.3.1 Oncologyand Endocrinology
5.3.2 Hepatitis and Retrovirus
5.3.3 Cardiac Markers
5.3.4 Infectious Diseases
5.3.5 Others
5.4. Market Analysis, Insights and Forecast By End User
5.4.1 Clinical Laboratories
5.4.2 Hospitals
5.4.3 Physician’s Offices
5.4.4 Others
5.5. Market Analysis, Insights and Forecast By Region
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East and Africa
6. North America Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast By Product
6.2.1 Instruments
6.2.2 Reagents and Consumables
6.3. Market Analysis, Insights and Forecast By Application
6.3.1 Oncologyand Endocrinology
6.3.2 Hepatitis and Retrovirus
6.3.3 Cardiac Markers
6.3.4 Infectious Diseases
6.3.5 Others
6.4. Market Analysis, Insights and Forecast By End User
6.4.1 Clinical Laboratories
6.4.2 Hospitals
6.4.3 Physician’s Offices
6.4.4 Others
6.5. Market Analysis, Insights and Forecast By Country
6.5.1 USA
6.5.2 Canada
7. Europe Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast By Product
7.2.1 Instruments
7.2.2 Reagentsand Consumables
7.3. Market Analysis, Insights and Forecast By Application
7.3.1 Oncologyand Endocrinology
7.3.2 Hepatitis and Retrovirus
7.3.3 Cardiac Markers
7.3.4 Infectious Diseases
7.3.5 Others
7.4. Market Analysis, Insights and Forecast By End User
7.4.1 Clinical Laboratories
7.4.2 Hospitals
7.4.3 Physician’s Offices
7.4.4 Others
7.5. Market Analysis, Insights and Forecast By Country/ Sub-region
7.5.1 UK
7.5.2 Germany
7.5.3 France
7.5.4 Italy
7.5.5 Spain
7.5.6 Scandinavia
7.5.7 Rest of Europe
8. Asia Pacific Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast By Product
8.2.1 Instruments
8.2.2 Reagentsand Consumables
8.3. Market Analysis, Insights and Forecast By Application
8.3.1 Oncologyand Endocrinology
8.3.2 Hepatitis and Retrovirus
8.3.3 Cardiac Markers
8.3.4 Infectious Diseases
8.3.5 Others
8.4. Market Analysis, Insights and Forecast By End User
8.4.1 Clinical Laboratories
8.4.2 Hospitals
8.4.3 Physician’s Offices
8.4.4 Others
8.5. Market Analysis, Insights and Forecast By Country/ Sub-region
8.5.1 Japan
8.5.2 China
8.5.3 India
8.5.4 Australia
8.5.5 Southeast Asia
8.5.6 Rest ofAsia Pacific
Continued…
This Report Answers the Following Questions:
Order Full Report:https://www.fortunebusinessinsights.com/checkout-page/100444
More Trending Topics From Fortune Business Insights@
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Immunodiagnostics Market – Global Trends, Industry Analysis, Size, Share, Growth and Forecast 2020 – 2025